“华法林 (Warfarin)”是一种处方血液稀释剂的通用名,该药物于 20 世纪 50 年代上市,经常在电视上观看最新药物广告的人可能会对其感到很熟悉。 这些广告称,这种新型血液稀释剂用于预防中风等重大疾病,服用更方便或副作用更少。 虽然后期的竞争对手一直 ...
Get detailed information on Warfarin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
The most common manifestation of pharmacokinetic interactions with warfarin involves the inhibition or induction of its metabolism. Attention should be paid to the relative importance of the ...
A phase IIa trial has demonstrated that a structural analogue of warfarin is safe, tolerable, and efficacious. Investigators believe that this new anticoagulant, named tecarfarin, will be ...
Compared to warfarin, edoxaban was as effective -- or even more so -- in preventing stroke and blood clots, researchers said.
The adjusted risk of major hemorrhage was more than twofold greater among patients with severe CKD Patients with chronic kidney disease (CKD) might require lower starting doses of the ...
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...
Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...
The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional ...